Industry Insights

The Reclassification Of Cannabis Could Reshape Insurance Access

A recent executive order signed by President Trump in December 2025, proposing the reclassification of cannabis from a Schedule I to a Schedule III controlled substance, represents a potential inflection point for the cannabis insurance market in the U.S.

While the reclassification would not legalize cannabis at the federal level, it would narrow the gap between federal and state regulations, reducing legal ambiguity and possibly unlocking broader financial system access.1 For insurers, this could mean improved pricing dynamics, and shifts in where and how coverage is placed. Currently, the medical use of cannabis has been legalized in 42 states and the District of Columbia.2

Current market structure: reliance on E&S

For over a decade, cannabis operators have relied on the excess and surplus (E&S) market for insurance coverage. With traditional admitted carriers largely remaining on the sidelines, primarily due to federal illegality and regulatory concerns, the E&S market has provided custom solutions including crop and property, general liability and product liability.

Cannabis-based businesses include wholesalers, retail distributors, hydroponic shops, and dispensaries. Most policies cover theft, property damage, crop loss, and liability claims. This risk segment has commanded elevated premiums due to:

  • Cash-heavy operations lacking formal banking infrastructure.
  • High-value inventory susceptible to theft or spoilage.
  • Emerging product liability exposures (e.g., edibles, vape devices).
  • Lack of long-term loss data for actuarial modeling.

Why reclassification of cannabis matters

The proposed federal reclassification would reclassify cannabis from the Schedule I category (which includes heroin and LSD) to Schedule III, recognizing medical use and likely reducing the severity of federal penalties.3 This could lead to cannabis businesses gaining access to banking services, federal tax benefits, and commercial credit. However, because the reclassification would not federally legalize marijuana, cannabis firms would still be subject to federal anti-money laundering regulations.

According to AM Best, the executive order does not guarantee access to banking or insurance, but could reduce the perceived risk profile of the cannabis sector. Increased financial access generally leads to a more formalized and less risky business environment, which ultimately leads to more capacity and better pricing for insurance coverages.

Strategic implications for the insurance sector

Here are four ways that the potential reclassification of cannabis could impact the insurance industry, including more competitive pricing, increased opportunities for brokers with expertise in the sector, and greater participation by admitted carriers.

  1. Admitted carriers may play a larger role in the sector. Reclassification may create regulatory clarity and a more favorable compliance environment, leading to national carriers entering select lines. This would diversify capacity, potentially reducing the concentration of cannabis business in the E&S sector.
  2. Pricing could become more competitive. More entrants, particularly from the admitted firms, could increase rate competition. While beneficial to cannabis operators, this would likely decrease premium margins for E&S carriers and MGAs currently writing the business.
  3. MGAs will continue to play an important role. Even with broader market participation, managing general agents (MGAs) will remain critical. Expertise in cannabis-specific underwriting, claims handling, and regulatory nuance will continue to differentiate those that have developed technical depth in the space.
  4. M&A activity could increase in the sector. Improved access to insurance and tax normalization could enhance valuations and reduce cost of capital for cannabis operators. This could accelerate M&A activity in the sector, potentially putting smaller accounts at risk but also creating strategic growth opportunities for brokers and MGAs with deep expertise and relationships in the sector.

Conclusion

If fully enacted, the reclassification of cannabis to Schedule III could influence the insurance landscape for an industry that has operated in regulatory ambiguity. It would represent a move toward normalization, potentially enabling greater access to capital, stabilizing coverage, and expanding carrier participation.

The insurance brokerage firms with underwriting expertise, claims infrastructure, and carrier relationships built during cannabis’ high-risk era will be best positioned to benefit in the next phase of market maturity.

Contributions to this article by: Pete Kampf, Vice President, MarshBerry.

Sources:

  1. https://www.debevoise.com/insights/publications/2025/12/federal-cannabis-developments-executive-order-on
  2. https://mjbizdaily.com/map-of-us-marijuana-legalization-by-state/
  3. https://vicentellp.com/insights/cannabis-rescheduling-explained/